Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

GlaxoSmithKline Pharmaceuticals Limited

Drug Manufacturers - General | Healthcare

Company Overview

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. It provides vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella, and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also offers specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Key Information

Market Cap

552279015424

Current Price

3098.6

52 Week Range

1921.0 - 3515.7

Previous Close

3119.1

Open

3134.0

Industry

Drug Manufacturers - General

Sector

Healthcare

Contact Details

Address

GSK House, Dr. Annie Besant Road Worli, Mumbai, 400030, India

Phone

+91-22249-59595

Fax

+91-22249-59494

Website

https://india-pharma.gsk.com

Financials

Day Low

3088.0

Day High

3152.2

Dividend Yield

1.35

PE Ratio

56.440804

Earnings Per Share

54.9

Beta

0.041

EBITDA

11527068672

Book Value

115.185

EPS

61.375

Company Officers

Name	Title	Age	Year Born
Mr. Bhushan Akshikar	MD & Executive Director	-	-
Mr. Juby Chandy	Whole-Time Director & CFO	46	1978
Ms. Aparajita Rajput	Vice President of Technology	-	-
Mr. Ajay Avinash Nadkarni	VP of Administration & Real Estate and Company Secretary	-	-
Mr. Amit G. Pandey	Executive Vice President of Legal	-	-
Ms. Simrat Sohal	Vice President of Ethics & Compliance	-	-
Mr. Carson Dalton	Executive Vice President of Communications & Government Affairs	-	-
Mr. Harsh V. Trehan	Country HR Head of India	-	-
Ms. Sukanya Choudhary	Head of Growth Emerging Market	-	-
Ms. Sharmishta Mitra	Commercial Head - Paediatric Vaccines	-	-